e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Treatment and control of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do we treat mycoplasma pneumoniae infections differently during an epidemic?
Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tatjana Mrvic, Darja Keše, Rok Kogoj
Source:
International Congress 2015 – Treatment and control of respiratory disease
Session:
Treatment and control of respiratory disease
Session type:
Thematic Poster Session
Number:
4063
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tatjana Mrvic, Darja Keše, Rok Kogoj. Do we treat mycoplasma pneumoniae infections differently during an epidemic?. Eur Respir J 2015; 46: Suppl. 59, 4063
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Mycoplasma pneumoniae
infections in a paediatric setting; changes in epidemiology and clinical presentation
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Community-acquired pneumonia (CAP) caused by
mycoplasma pneumoniae
or
chlamydophila pneumoniae
in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Klebsiella respiratory infection community acquired
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Is doxycycline the right choice to treat an acute respiratory
chlamydia psittaci
infection?
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
High prevalence of resistant bacterial infections in patients with tracheostomy due to neuromuscular disease (NMD)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Resistance of respiratory isolates of klebsiella pneumoniae from patients in pediatric cardiac surgery department
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Prevalence of group A β-haemolytic streptococcus among children with pharyngitis in Ethiopia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Emerging macrolide-resistant
mycoplasma pneumoniae
in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
How dangerous are respiratory tract infections with enterovirus D68?
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020
Common organisms causing community acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Extended-spectrum-beta-lactamase producing multidrug resistant nosocomial bacterial isolates causing lower respiratory tract infection in Tertiary Care Hospital, Nepal
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Clinical impact of rhinovirus infections in infancy
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of
streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004
Do school holidays affect adult pneumococcal community acquired pneumonia incidence?
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept